CMV (cytomegalovirus) infection in infant with leukocytosis without symptoms: A Case Report A Case Report of CMV
Archives of Advances in Biosciences,
Vol. 12 No. 3 (2021),
10 Tir 2021
,
Page 92-98
https://doi.org/10.22037/aab.v12i3.35235
Abstract
Introduction: CMV is an infectious disease usually transfer from pregnant women to the fetus, or during breastfeeding transfer to the infant and have signs and symptoms like losing weight at birth, leukocytosis, diarrhea.
Case presentation: In this case, the one year old girl does not has any sign and symptoms except leukocytosis and the infant mothers does not has any disease during pregnancy. The experiments were prescribed for diagnosing the reason of leukocytosis were CBC, Urine analysis, Immunoassay tests for EBV and CMV and serologic tests for Covid19, wright and Widal agglutination and 2ME tests for Brucella.
Conclusions: The results showed the rate of IgM and IgG Antibody were 27.688 and 228.761 respectively. It is noteworthy that there were no other signs and symptoms in this baby, which are commonly described for CMV infection, and other tests have been reported as usual.
- Cytomegalovirus Infections, Infectious Disease Transmission, Case Reports, Leukocytosis, Infant, Splenomegaly.
How to Cite
References
Tanimura K, Yamada H. Potential biomarkers for predicting congenital cytomegalovirus infection. Int J Mol Sci. 2018;19(12):3760.
La Rosa C, Diamond DJ. The immune response to human CMV. Future Virol [Internet]. 2012 Mar 1;7(3):279–93. Available from: https://doi.org/10.2217/fvl.12.8
Pinninti S, Hough-Telford C, Pati S, Boppana S. Cytomegalovirus and Epstein-Barr Virus Infections. Pediatr Rev. 2016;37(6):223–34.
Pass RF, Arav-Boger R. Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention. F1000Research [Internet]. 2018 Mar 1;7:255. Available from: https://pubmed.ncbi.nlm.nih.gov/29560263
Cannon MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol. 2009;46:S6–10.
Nolan N, Halai UA, Regunath H, Smith L, Rojas-Moreno C, Salzer W. Primary cytomegalovirus infection in immunocompetent adults in the United States–A case series. IDCases. 2017 Jan 1;10:123-6.
Kagan KO, Hamprecht K. Cytomegalovirus infection in pregnancy. Arch Gynecol Obstet. 2017;296(1):15–26.
Koch S, Larbi A, Oezcelik D, Solana R, Gouttefangeas C, Attig S, et al. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci. 2007;1114(1):23–35.
Frasca D, Blomberg BB. Aging, cytomegalovirus (CMV) and influenza vaccine responses. Hum Vaccin Immunother. 2016;12(3):682–90.
Coll O, Benoist G, Ville Y, Weisman LE, Botet F, Greenough A, et al. Guidelines on CMV congenital infection. J Perinat Med. 2009;37(5):433–45.
Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86–102.
De Santis M, Apicella M, De Luca C, D’Oria L, Valentini P, Sanguinetti M, et al. Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: A case-series. J Clin Virol. 2020;127:104351.
Prodan N, Sonek J, Wagner P, Hoopmann M, Abele H, Hamprecht K, et al. Splenic artery blood flow as a potential marker for materno-fetal transmission of a primary CMV infection. Arch Gynecol Obstet. 2019;299(5):1289–94.
Mussi-Pinhata MM, Yamamoto AY. Natural history of congenital cytomegalovirus infection in highly seropositive populations. J Infect Dis. 2020;221(Supplement_1):S15–22.
Simonazzi G, Curti A, Cervi F, Gabrielli L, Contoli M, Capretti MG, et al. Perinatal outcomes of non-primary maternal cytomegalovirus infection: a 15-year experience. Fetal Diagn Ther. 2018;43(2):138–42.
Lawrence RM. Transmission of infectious diseases through breast milk and breastfeeding. In: Breastfeeding. Elsevier; 2022. p. 393–456.
Bhide A, Papageorghiou AT. Managing primary CMV infection in pregnancy. Obstet Anesth Dig. 2009;29(1):9.
Lawrence RM. Host-resistance factors and immunologic significance of human milk. In: Breastfeeding. Elsevier; 2022. p. 145–92.
Xing C, Liang B, Wu J, Yang Q, Hu G, Yan Y, et al. Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia. Cancer Manag Res. 2018;10:625.
A Ross S, Novak Z, Pati S, B Boppana S. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Targets (Formerly Curr Drug Targets-Infectious Disord. 2011;11(5):466–74.
Blázquez-Gamero D, Galindo Izquierdo A, Del Rosal T, Baquero-Artigao F, Izquierdo Méndez N, Soriano-Ramos M, et al. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid. J Matern Neonatal Med. 2019;32(4):617–25.
Marsico C, Kimberlin DW. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr. 2017;43(1):1–8.
- Abstract Viewed: 276 times
- PDF Downloaded: 194 times